Bank of America Is Not Cheap Anymore

Bank of America Corp (NYSE:BAC) was a great value stock in the first half of the year. Investors had been worried that the bank would prove to be “too big to succeed” as it consisted of a giant financial company with many different business interests. It had also been the target of consumer activists who were furious at the bank’s plan to begin charging a fee for providing debit card services to its customers. These and other pressures caused the stock to trade at a remarkable discount to its book value and to the earnings multiples of its peers. But then the market did its job. Bank of America Corp is up 68% year to date and as of this writing is close to $10 per share, a level it last reached in July 2011.

FAIRHOLME (FAIRX) Bruce Berkowitz

In the third quarter, Bank of America’s revenue and earnings were both down substantially from the figures from the third quarter of 2011. The top line declined by 26%, which nearly wiped out the bank’s earnings; net income was also down relative to each of the intervening three quarters. The bank still trades at a large discount to the book value of its equity: Bank of America’s P/B ratio is 0.5. However, book value per share has not increased in the last year (though tangible book value has). In addition, the company’s quarterly report shows that it is certainly shrinking its operations: compared to a year earlier, the number of banking centers, ATMs, and employees decreased by 3%, 8%, and 6% respectively. On an earnings basis, the valuation isn’t quite as good relative to other banks as Bank of America Corp trades at 10 times consensus earnings for 2013.

Bruce Berkowitz’s Fairholme was the largest holder of the stock out of the funds and other notable investors tracked in our database of 13F filings at the end of June, reporting a position of just over 100 million shares (find more of Bruce Berkowitz’s favorite stocks). Platinum Asset Management, an Australian fund managed by Kerr Neilson, increased its stake by 17% during the second quarter to a total of 35 million shares (see more stock picks from Platinum Asset Management).

We can compare Bank of America to Citigroup Inc. (NYSE:C), Wells Fargo & Company (NYSE:WFC), JPMorgan Chase & Co. (NYSE:JPM), and PNC Financial Services (NYSE:PNC). Citigroup has been another value bank that was accused of being overstretched, and that company still carries a low P/B of 0.6 but also trades at 8 times forward earnings estimates. It too saw a large decline in revenue in its most recent quarter compared to the same period last year, which brought earnings down 88%. Read our recent analysis of Citigroup. JPMorgan Chase, like Citi, has a forward P/E of 8 and with investors considering it a more stable bank it is priced at only a small discount to book value- the P/B ratio is 0.9. And its business is doing considerably better, with revenue and earnings considerably higher in the third quarter than in Q3 2011. We’d rather own it than Bank of America.

PNC is priced similarly to JPMorgan Chase: its P/B is 0.9, and its forward P/E is 9. We don’t see it as an equivalent investment, however, because while the bank did grow its business last quarter the growth rate was well below what JPMorgan Chase achieved (earnings were up 10% from Q3 2011). It is also smaller in terms of market capitalization, and carries a higher trailing earnings multiple as well (of course, it might still look better than Bank of America or Citi). Wells Fargo’s stock price has lagged in recent months as many of these banks have rallied- it is only up 20% so far this year, trailing all of these peers we’ve discussed except for PNC- but it is still perceived as the safest, most reliable bank for investors. As its earnings have grown, its earnings multiples have come closer to the same ~10 range and so it may become a buying opportunity soon even though it actually trades at a premium to the book value of its equity.

Bank of America is cheap on a book basis, and we like that it is making progress in reducing costs. However, other banks such as JPMorgan Chase are also trading at a discount to book value (though a much smaller one) and appear to be doing a superior job at generating income from those assets and at growing their businesses.

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!